Jenna Dombroski

  • Vanderbilt University

    Dissertation Defense: Jenna Dombroski, Biomedical Engineering

    DISSERTATION DEFENSE Jenna Dombroski, Biomedical Engineering *under the direction of Mike King “Nano-vaccines and dendritic cell processing for anti-cancer therapies” 05.18.23  |  12:00PM CST  |  5326 Stevenson Center  |   Zoom 1 in 8 women are diagnosed with breast cancer in her lifetime, representing a need for effective preventative measures… Read More

    May. 9, 2023

  • Spotlight Podcast Episode 14: Jenna Dombroski – progress toward a breast cancer vaccine!

    Spotlight Podcast Episode 14: Jenna Dombroski – progress toward a breast cancer vaccine!

    Episode 14 of the VINSE Spotlight Podcast Alice Leach talks with Jenna A. Dombroski about progress toward a breast cancer vaccine!  Jenna’s paper “Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer” was published in Langmuir.  Jenna is a prior VINSE REU student and… Read More

    Aug. 4, 2020

  • VINSE researchers developed a promising treatment for breast cancer metastasis

    VINSE researchers developed a promising treatment for breast cancer metastasis

    Updated June 13, 2020 (Precision Vaccinations)With a surprisingly simple approach in which cancer cells are first grown, ruptured and converted into nanoparticles, and then used as a vaccine, Vanderbilt University researchers say they have developed what appears to be a promising treatment for breast cancer metastasis. Metastasis is… Read More

    Jun. 16, 2020

  • Congratulations 2020 VINSE REU NSF GRFP Winners!

    Congratulations 2020 VINSE REU NSF GRFP Winners!

    Three prior VINSE REU students were awarded prestigious NSF Graduate Research Fellowships this year. NSF Fellows receive a three-year annual stipend of $34,000 along with a $12,000 allowance for tuition and fees for a research-based master’s or doctoral degree in in NSF-supported science, technology, engineering, and mathematics disciplines. Annually, the… Read More

    Apr. 22, 2020